mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.2 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.2 |